The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19
about
Distribution of CYP2C19 polymorphisms in Mongolian and Han nationals and the choice of specific antiplatelet drugs.Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivity.The pharmacogenetics of medications used in general anesthesia.Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells.Comparison of a rapid point-of-care and two laboratory-based CYP2C19*2 genotyping assays for personalisation of antiplatelet therapy.
P2860
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19
@ast
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19
@en
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19
@nl
type
label
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19
@ast
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19
@en
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19
@nl
prefLabel
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19
@ast
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19
@en
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19
@nl
P2860
P1476
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19
@en
P2093
Joshua P Lewis
P2860
P304
P356
10.1517/17425255.2015.1068757
P407
P577
2015-07-14T00:00:00Z